Milestone Pharmaceuticals Inc. (MIST)

NASDAQ: MIST · IEX Real-Time Price · USD

1.630

-0.010 (-0.61%)

At close: Apr 22, 2024, 4:00 PM

1.642

+0.012 (0.74%)

After-hours: Apr 22, 2024, 5:07 PM EDT

Milestone Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017
Net Income	-59.69	-58.39	-42.85	-49.97	-55.23	-23.19	-8.09
Depreciation & Amortization	0.09	0.09	0.09	0.1	0.04	0.01	0.01
Share-Based Compensation	9.53	9.05	7.28	4.95	1.19	0.63	0.19
Other Operating Activities	3.64	-3.22	2.26	-5.81	2.85	1.5	-0.16
Operating Cash Flow	-46.42	-52.47	-33.22	-50.73	-51.15	-21.05	-8.05
Capital Expenditures	-0.11	-0.27	0	0	-0.41	-0.01	-0.04
Change in Investments	4.87	-56.85	70	-70	0.03	16	-15.99
Investing Cash Flow	4.76	-57.12	70	-70	-0.38	16	-16.02
Share Issuance / Repurchase	0.58	3.09	0.12	73.22	85.41	0.46	0.02
Debt Issued / Paid	47.22	0	0	0	0	0	0
Other Financing Activities	-0.01	-	4.93	-	-	79.65	30.7
Financing Cash Flow	47.79	3.09	5.06	73.22	85.41	80.12	30.72
Net Cash Flow	6.12	-106.51	41.83	-47.51	33.87	75.07	6.65
Free Cash Flow	-46.54	-52.74	-33.22	-50.73	-51.57	-21.05	-8.09
Free Cash Flow Margin	-4653.60%	-1054.82%	-221.49%	-	-	-	-
Free Cash Flow Per Share	-1.08	-1.24	-0.79	-1.73	-3.27	-65.95	-34.16

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).